Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 6:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1969–1992 of 35,388 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: alone Clear all

Conditions: Hodgkin Disease
Interventions: brentuximab vedotin, bendamustine; Drug
Lead sponsor: Seagen Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 13
States / cities: Birmingham, Alabama • San Francisco, California • Stanford, California + 10 more

Conditions: Responsible Fatherhood
Interventions: Intervention - Responsible Fatherhood Programming; Other
Lead sponsor: Partnership for Maternal & Child Health of Northern New Jersey; Other
Eligibility: 18 Years and older · Male only
Enrollment: 540 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Physical Activity in Children
Interventions: UNICEF kid power program immediately, UNICEF kid power program for waitlist control, ActiGraph Accelerometer; Behavioral · Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 8 Years to 11 Years
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Polyneuropathies
Interventions: HB-adMSCs; Biological
Lead sponsor: Hope Biosciences Research Foundation; Industry
Eligibility: Not listed
U.S. locations: 1
States / cities: Sugar Land, Texas

Conditions: Colorectal Cancer Screening
Interventions: Phone call, Mailed FIT Kit; Behavioral · Other
Lead sponsor: University of Southern California; Other
Eligibility: 45 Years to 59 Years
Enrollment: 2,135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Martinez, California

Conditions: Chronic Pain, Generalized Anxiety Disorder
Interventions: Low Intensity Focused Ultrasound; Device
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Healthy
Interventions: warfarin; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pre-diabetes
Interventions: Receive lifestyle modification alone, Metformin therapy; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 65 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Breast Lesions
Interventions: SAVI Scout®; Device
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Duchenne Muscular Dystrophy
Interventions: AVI-4658 (Eteplirsen), Placebo; Drug · Other
Lead sponsor: Sarepta Therapeutics, Inc.; Industry
Eligibility: 7 Years to 13 Years · Male only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Spinal Cord Injury
Interventions: STDP, Training, Sham STDP, Multisite-STDP; Other · Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 85 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Hines, Illinois

Conditions: Pain Management After Breast Biopsy
Interventions: Lidocaine Ropivacaine, Lidocaine alone; Drug
Lead sponsor: TriHealth Inc.; Other
Eligibility: 18 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Surgical Site Infections, Nosocomial Infection, Healthcare Associated Infections
Interventions: methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation; Combination Product
Lead sponsor: Ondine Biomedical Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Savannah, Georgia

Conditions: Advanced Solid Tumors
Interventions: Venetoclax, Rovalpituzumab Tesirine, ABBV-181; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 5
States / cities: La Jolla, California • Chicago, Illinois • Huntersville, North Carolina + 2 more

Conditions: Postoperative Wound Complications
Interventions: Negative pressure wound therapy; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 10 Years to 64 Years · Female only
Enrollment: 441 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Influenza, Healthy
Interventions: Fluzone®, FluMist®; Biological
Lead sponsor: Stanford University; Other
Eligibility: 6 Months to 10 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Depression, Major Depressive Disorder, Suicidal Ideation
Interventions: Single-Pulse Transcranial Magnetic Stimulation, EEG-Synchronized Repetitive Transcranial Magnetic Stimulation (rTMS), Cognitive Behavioral Therapy (CBT), Cognitive Flexibility and Emotion Regulation Tasks; Device · Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Healthy Volunteer
Interventions: [14C]-GDC-0980; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Pregnancy
Interventions: Use of Ultrasound, No ultrasound used; Device · Procedure
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Eligibility: 18 Years to 48 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Multiple Myeloma
Interventions: Mapatumumab, Bortezomib; Biological · Drug
Lead sponsor: Human Genome Sciences Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 8
States / cities: Scottsdale, Arizona • La Jolla, California • Lecanto, Florida + 5 more

Conditions: Generalized Myasthenia Gravis
Interventions: Whole-body Electrical Muscle Stimulation Exercise; Device
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Fairway, Kansas • Columbia, Missouri

Conditions: Pelvic Floor Disorders, Stress Urinary Incontinence, Pelvic Organ Prolapse
Interventions: Written Handouts, Interactive Workshop; Other
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Non-Small Cell Lung Cancer, Advanced Solid Tumours
Interventions: AZD4785; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 3
States / cities: Sarasota, Florida • Boston, Massachusetts • Nashville, Tennessee

Conditions: Maternal Immunization
Interventions: Prevention, Maternal Immunization; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 15 Years and older · Female only
Enrollment: 1,350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Search by objective public record fields.

Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma

Evaluation of the FELLAS Responsible Fatherhood Project

Web-based Physical Activity Intervention for Children

Individual Patient Expanded Access IND to Treat Polyneuropathy

Randomized Trial of Follow-up to Mailed FIT Kits

LIFU for Chronic Pain and Generalized Anxiety Disorder

Assessment of 2012 Bioequivalence Standards for Warfarin

Preventing Diabetes in the Deep South: Extending Partnerships and Adapting Interventions to Reach Rural Communities at High Risk.

Single Step Lesion Annotation and Localization of Suspicious Breast Lesions

Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients

Enhancing STDP After Spinal Cord Injury

Comparison of Long vs. Short Acting Anesthesia for Improving Pain Management After Breast Biopsy

Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Negative Pressure Wound Therapy in Cesarean Section

The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection

RECOVERS - Realigning Emotion and COgnition Via prEcision Regulation networkS

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects

Does Ultrasound Help With Placement of Labor Analgesia in Pregnant Patients?

Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis

Educating Women About Pelvic Floor Disorders During Pregnancy

Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours

Adapting Motivational Interviewing for Maternal Immunizations (MI4MI)